NEUROLEPSIN

This brand name is authorized in Austria

Active ingredients

The drug NEUROLEPSIN contains one active pharmaceutical ingredient (API):

1 Lithium
UNII 2BMD2GNA4V - LITHIUM CARBONATE

Little is known about the way the lithium ion can modify neurotransmission within the CNS. Many of the proposed mechanisms have suggested an inhibitory effect on components of various neurotransmitter signalling pathways, such as cyclic AMP formation, cyclic GMP formation, G-proteins or inositol phosphate metabolism.

Read about Lithium

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N05AN01 Lithium N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AN Lithium
Discover more medicines within N05AN01

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.